| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Normal phase NEGATIVE ION MODE | Nov5_2018_032 | siRNA:ACSL1 | Treatment (8hrs):eleostearic acid (25µM) | pmol/umol |
| Normal phase NEGATIVE ION MODE | Nov5_2018_034 | siRNA:ACSL1 | Treatment (8hrs):eleostearic acid (25µM) | pmol/umol |
| Normal phase NEGATIVE ION MODE | Nov5_2018_036 | siRNA:ACSL1 | Treatment (8hrs):eleostearic acid (25µM) | pmol/umol |
| Normal phase NEGATIVE ION MODE | Nov5_2018_026 | siRNA:ACSL1 | Treatment (8hrs):Vehicle (methanol) | pmol/umol |
| Normal phase NEGATIVE ION MODE | Nov5_2018_028 | siRNA:ACSL1 | Treatment (8hrs):Vehicle (methanol) | pmol/umol |
| Normal phase NEGATIVE ION MODE | Nov5_2018_030 | siRNA:ACSL1 | Treatment (8hrs):Vehicle (methanol) | pmol/umol |
| Normal phase NEGATIVE ION MODE | Nov5_2018_021 | siRNA:Control | Treatment (8hrs):eleostearic acid (25µM) | pmol/umol |
| Normal phase NEGATIVE ION MODE | Nov5_2018_023 | siRNA:Control | Treatment (8hrs):eleostearic acid (25µM) | pmol/umol |
| Normal phase NEGATIVE ION MODE | Nov5_2018_025 | siRNA:Control | Treatment (8hrs):eleostearic acid (25µM) | pmol/umol |
| Normal phase NEGATIVE ION MODE | Nov5_2018_015 | siRNA:Control | Treatment (8hrs):Vehicle (methanol) | pmol/umol |
| Normal phase NEGATIVE ION MODE | Nov5_2018_017 | siRNA:Control | Treatment (8hrs):Vehicle (methanol) | pmol/umol |
| Normal phase NEGATIVE ION MODE | Nov5_2018_019 | siRNA:Control | Treatment (8hrs):Vehicle (methanol) | pmol/umol |
| Reversed phase POSITIVE ION MODE | Jun17_2020_063 | siRNA:ACSL1 | Treatment (8hrs):eleostearic acid (25µM) | pmol/mg |
| Reversed phase POSITIVE ION MODE | Jun17_2020_067 | siRNA:ACSL1 | Treatment (8hrs):eleostearic acid (25µM) | pmol/mg |
| Reversed phase POSITIVE ION MODE | Jun17_2020_071 | siRNA:ACSL1 | Treatment (8hrs):eleostearic acid (25µM) | pmol/mg |
| Reversed phase POSITIVE ION MODE | Jun17_2020_051 | siRNA:ACSL1 | Treatment (8hrs):Vehicle (methanol) | pmol/mg |
| Reversed phase POSITIVE ION MODE | Jun17_2020_055 | siRNA:ACSL1 | Treatment (8hrs):Vehicle (methanol) | pmol/mg |
| Reversed phase POSITIVE ION MODE | Jun17_2020_059 | siRNA:ACSL1 | Treatment (8hrs):Vehicle (methanol) | pmol/mg |
| Reversed phase POSITIVE ION MODE | Jun17_2020_039 | siRNA:Control | Treatment (8hrs):eleostearic acid (25µM) | pmol/mg |
| Reversed phase POSITIVE ION MODE | Jun17_2020_043 | siRNA:Control | Treatment (8hrs):eleostearic acid (25µM) | pmol/mg |
| Reversed phase POSITIVE ION MODE | Jun17_2020_047 | siRNA:Control | Treatment (8hrs):eleostearic acid (25µM) | pmol/mg |
| Reversed phase POSITIVE ION MODE | Jun17_2020_027 | siRNA:Control | Treatment (8hrs):Vehicle (methanol) | pmol/mg |
| Reversed phase POSITIVE ION MODE | Jun17_2020_031 | siRNA:Control | Treatment (8hrs):Vehicle (methanol) | pmol/mg |
| Reversed phase POSITIVE ION MODE | Jun17_2020_035 | siRNA:Control | Treatment (8hrs):Vehicle (methanol) | pmol/mg |
Return to study ST001451 main page
Download data matrix(Eleostearic acid effects on TAGs and oxLipids Normal phase NEGATIVE ION MODE)
Download data matrix(Eleostearic acid effects on TAGs and oxLipids Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|